{"name":"Bacainn Therapeutics, Inc.","slug":"bacainn-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxNMVBaRmxTUlZYYlVWSDVjcTktZFljZjFfcE9VbDlMR29mYUNmdGhENU1KMTRoVG1NcnVtUVphMnJuMXB0V0tCb1ZGVFZIOVFPMDBjQ3NNTC1ETWdnOFJGTy12Y2VJM1VLbDZzYlQ0bmlGRlhBb0Y0dlpPZ2hwb213TW01Z1RETzBBTU9vbFdtcjhaZHdMZERpbWlRQ0dCa2c1SVB2MXVkWjJrSXk5V0Z4Z1VneTlreEFEX0h2dW54NGpnRGt0a29fLW5xZEZoMDg4V0dDRGhvMDV1Q3hmQTlNcmJieVBmTEdoRXlvZ0hvcXdqbDdFazdMSGEwSU4yQkFGdVg4R1Nla3lXQ19hOUtwX0lJZVlBLTFVQkpF?oc=5","date":"2024-07-15","type":"regulatory","source":"prnewswire.com","summary":"SKYRIZI's Approval For Ulcerative Colitis Treatment Expands AbbVie's Portfolio Across Immune-mediated Inflammatory Diseases | DelveInsight - prnewswire.com","headline":"SKYRIZI's Approval For Ulcerative Colitis Treatment Expands AbbVie's Portfolio Across Immune-mediated Inflammatory Disea","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPYmJuYkZSZEViU0V3Y1ZPTGJXZTdEcWJUZ2E1UkV1bVNKeGc1Mzd1ZlY1b3NYWk1sVklacnF6VFV5dG5FT0lSU09nOWREZWU1MUJtY1pPTnZUNlZBM3BoN1VrWHRtc0dfM3otNW1tcmQyRDZYQURVN1BqZmQxZjU0eXcxTlhMTEF6NDFhZ25iaHlEUk1oQmdlUUtMLTUtaHVBLVFEMEJIaUI5SGYyNkxHOGRzczRYQVNWUW9pcFA0dUY4Rnc?oc=5","date":"2023-02-03","type":"pipeline","source":"UMass Chan Medical School","summary":"NeuShen Therapeutics funds ALS research at UMass Chan Medical School - UMass Chan Medical School","headline":"NeuShen Therapeutics funds ALS research at UMass Chan Medical School","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPR1RPYW10eE9VbEVfcm1TV1dtaHFyVGlrXzd6Uy1jdmw0ZkNxRFRKZ3lnWG1IeTRPdF8wbk15d0ExZjVwUHFFSWNKX0ZCWmhnOGJFVkZtRjdmWWctRk8xX0twQjJkenlZdndlUUtoMmRPNlM4cEtCZXVaN3huS3R6cklSZlcxbWMzeWM3QTNlRnhiaHktMFRzNXMtR1R5TjcwX3V0Z3pvSHJHMzdibndmenhqZlhNV2pMWDN1a1ctd0puTXVMM0c2MDNJS1FKRDVaTTl6OGhNN1BJZkhxazVtaG1qbFAwOW9tbF9ucUNNOUQ5QQ?oc=5","date":"2023-01-10","type":"deal","source":"UMass Chan Medical School","summary":"UMass Chan licenses rights to spinal muscular atrophy gene therapy program to CANbridge Pharmaceuticals - UMass Chan Medical School","headline":"UMass Chan licenses rights to spinal muscular atrophy gene therapy program to CANbridge Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNY2YyREJtZWpFU08zdWpZOVRXTkkwTko2OTBnelh0ZzdndUZURnlzZllEcFNQT2ExemF6SGlQWWkzM0RZNHZmQXk5a3NIdDhzMnM5ZC1IaVRkYVh0VzE2QTYxUWg1VkhhQWN0amlJSEU1NEhpTFZVaUZEc05Ed1I3VnE0QlNLOThvVzluN2lvNDhPX0hZcE9LcFB1dFZVQ2tEX3RuRTFuMDk1MHhELWJ2X21ZR3FtZFROOGc?oc=5","date":"2022-03-10","type":"trial","source":"fiercebiotech.com","summary":"Morningside rolls up a pair of biotechs to birth clinical-phase inflammatory disease player - fiercebiotech.com","headline":"Morningside rolls up a pair of biotechs to birth clinical-phase inflammatory disease player","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}